Transforming Biomedical Research through High-Throughput Histology Slide Scanning in The Imaging Resource Facility

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

December 31, 2026
Response Due
Active
Status

Opportunity Overview

The histological examination of tissue is a widespread and a crucial part of disease diagnosis in a clinical setting. Furthermore, histology allows biomedical researchers to advance our understanding of disease, enabling breakthroughs in diagnosis, prevention and treatment. High-quality histology slide digitisation is vital for disease study and, compared to glass slides, high-resolution images are easier to store, analyse and share.
The Imaging Resource Facility (IRF) at City St George’s is a vital core facility providing researchers with access to state-of-the-art equipment and expert support. The IRF offers a comprehensive histology workflow involving sample preparation, embedding, sectioning and staining. The facility’s 10-year-old slide scanner has become a significant bottleneck in this process. This limitation not only hinders efficiency but also restricts the ability of researchers to undertake large-scale digitisation projects in the IRF. In addition, the inefficiencies of the current system impose unnecessary costs on researcher time, institutional resources and grant funding.
The NanoZoomer S60 is a high-throughput slide scanner that will revolutionise histological research at City St George’s. With ten times the scanning capacity of the IRF’s existing slide scanner, the S60 significantly enhances efficiency and enables researchers to undertake larger and more complex projects. Additionally, the S60 introduces fluorescence slide scanning capabilities, a technique not currently available in the IRF, opening new doors for biomedical research.
The S60 scanner will support and enable a diverse range of projects within the MRC remit to improve human health. These projects include advancing our understanding of the genetic causes of inherited cardiac conditions, improving the diagnosis and treatment of sudden cardiac death, and exploring the pathological mechanisms of microvascular disease. It will also aid research in neuromuscular disorders, venous...

This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedMay 30, 2026
Procurement stageActive solicitation
Response dueDecember 31, 2026
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Iron and immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.